| Product Code: ETC13202903 | Publication Date: Apr 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 150 | No. of Figures: 55 | No. of Tables: 32 |
North America Carrier Screening Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 North America Carrier Screening Market Overview |
3.1 North America Regional Macro Economic Indicators |
3.2 North America Carrier Screening Market Revenues & Volume, 2021 & 2031F |
3.3 North America Carrier Screening Market - Industry Life Cycle |
3.4 North America Carrier Screening Market - Porter's Five Forces |
3.5 North America Carrier Screening Market Revenues & Volume Share, By Countries, 2021 & 2031F |
3.6 North America Carrier Screening Market Revenues & Volume Share, By Test Type, 2021 & 2031F |
3.7 North America Carrier Screening Market Revenues & Volume Share, By Disease Type, 2021 & 2031F |
3.8 North America Carrier Screening Market Revenues & Volume Share, By Medical Condition, 2021 & 2031F |
3.9 North America Carrier Screening Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.10 North America Carrier Screening Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 North America Carrier Screening Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 North America Carrier Screening Market Trends |
6 North America Carrier Screening Market, 2021 - 2031 |
6.1 North America Carrier Screening Market, Revenues & Volume, By Test Type, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 North America Carrier Screening Market, Revenues & Volume, By Molecular Screening Test, 2021 - 2031 |
6.1.3 North America Carrier Screening Market, Revenues & Volume, By Biochemical Screening Test, 2021 - 2031 |
6.2 North America Carrier Screening Market, Revenues & Volume, By Disease Type, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 North America Carrier Screening Market, Revenues & Volume, By Cystic Fibrosis, 2021 - 2031 |
6.2.3 North America Carrier Screening Market, Revenues & Volume, By Tay-Sachs, 2021 - 2031 |
6.2.4 North America Carrier Screening Market, Revenues & Volume, By Gaucher Disease, 2021 - 2031 |
6.2.5 North America Carrier Screening Market, Revenues & Volume, By Sickle Cell Disease, 2021 - 2031 |
6.2.6 North America Carrier Screening Market, Revenues & Volume, By Spinal Muscular Atrophy, 2021 - 2031 |
6.2.7 North America Carrier Screening Market, Revenues & Volume, By Other Autosomal Recessive Genetic Disorders, 2021 - 2031 |
6.3 North America Carrier Screening Market, Revenues & Volume, By Medical Condition, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 North America Carrier Screening Market, Revenues & Volume, By Pulmonary Conditions, 2021 - 2031 |
6.3.3 North America Carrier Screening Market, Revenues & Volume, By Hematological Conditions, 2021 - 2031 |
6.3.4 North America Carrier Screening Market, Revenues & Volume, By Neurological Conditions, 2021 - 2031 |
6.3.5 North America Carrier Screening Market, Revenues & Volume, By Others, 2021 - 2031 |
6.4 North America Carrier Screening Market, Revenues & Volume, By Technology, 2021 - 2031 |
6.4.2 North America Carrier Screening Market, Revenues & Volume, By DNA Sequencing, 2021 - 2031 |
6.4.3 North America Carrier Screening Market, Revenues & Volume, By Polymerase Chain Reaction, 2021 - 2031 |
6.4.4 North America Carrier Screening Market, Revenues & Volume, By Microarrays, 2021 - 2031 |
6.4.5 North America Carrier Screening Market, Revenues & Volume, By Others, 2021 - 2031 |
6.5 North America Carrier Screening Market, Revenues & Volume, By End User, 2021 - 2031 |
6.5.1 Overview & Analysis |
6.5.2 North America Carrier Screening Market, Revenues & Volume, By Hospitals, 2021 - 2031 |
6.5.3 North America Carrier Screening Market, Revenues & Volume, By Reference Laboratories, 2021 - 2031 |
6.5.4 North America Carrier Screening Market, Revenues & Volume, By Physician Offices and Clinics, 2021 - 2031 |
6.5.5 North America Carrier Screening Market, Revenues & Volume, By Others, 2021 - 2031 |
7 North America Carrier Screening Market, By Countries, 2021 - 2031 |
7.1 Overview & Analysis |
7.2 North America Carrier Screening Market, Revenues & Volume, By Test Type, 2021 - 2031 |
7.2.1 United States (US) Carrier Screening Market, Revenues & Volume, By Test Type, 2021 - 2031 |
7.2.2 Canada Carrier Screening Market, Revenues & Volume, By Test Type, 2021 - 2031 |
7.2.3 Rest of North America Carrier Screening Market, Revenues & Volume, By Test Type, 2021 - 2031 |
7.3 North America Carrier Screening Market Revenues & Volume Share, By Disease Type, 2021 & 2031F |
7.3.1 United States (US) Carrier Screening Market, Revenues & Volume, By Disease Type, 2021 - 2031 |
7.3.2 Canada Carrier Screening Market, Revenues & Volume, By Disease Type, 2021 - 2031 |
7.3.3 Rest of North America Carrier Screening Market, Revenues & Volume, By Disease Type, 2021 - 2031 |
7.4 North America Carrier Screening Market, Revenues & Volume, By Medical Condition, 2021 - 2031 |
7.4.1 United States (US) Carrier Screening Market, Revenues & Volume, By Medical Condition, 2021 - 2031 |
7.4.2 Canada Carrier Screening Market, Revenues & Volume, By Medical Condition, 2021 - 2031 |
7.4.3 Rest of North America Carrier Screening Market, Revenues & Volume, By Medical Condition, 2021 - 2031 |
7.5 North America Carrier Screening Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.5.1 United States (US) Carrier Screening Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.5.2 Canada Carrier Screening Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.5.3 Rest of North America Carrier Screening Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.6 North America Carrier Screening Market, Revenues & Volume, By End User, 2021 - 2031 |
7.6.1 United States (US) Carrier Screening Market, Revenues & Volume, By End User, 2021 - 2031 |
7.6.2 Canada Carrier Screening Market, Revenues & Volume, By End User, 2021 - 2031 |
7.6.3 Rest of North America Carrier Screening Market, Revenues & Volume, By End User, 2021 - 2031 |
8 North America Carrier Screening Market Key Performance Indicators |
9 North America Carrier Screening Market - Export/Import By Countries Assessment |
10 North America Carrier Screening Market - Opportunity Assessment |
10.1 North America Carrier Screening Market Opportunity Assessment, By Countries, 2021 & 2031F |
10.2 North America Carrier Screening Market Opportunity Assessment, By Test Type, 2021 & 2031F |
10.3 North America Carrier Screening Market Opportunity Assessment, By Disease Type, 2021 & 2031F |
10.4 North America Carrier Screening Market Opportunity Assessment, By Medical Condition, 2021 & 2031F |
10.5 North America Carrier Screening Market Opportunity Assessment, By Technology, 2021 & 2031F |
10.6 North America Carrier Screening Market Opportunity Assessment, By End User, 2021 & 2031F |
11 North America Carrier Screening Market - Competitive Landscape |
11.1 North America Carrier Screening Market Revenue Share, By Companies, 2022 |
11.2 North America Carrier Screening Market Competitive Benchmarking, By Operating and Technical Parameters |
12 Top 10 Company Profiles |
13 Recommendations |
14 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here